Potential mechanisms and therapeutic targets of mesenchymal stem cell transplantation for ischemic stroke

Li Zhou,Huimin Zhu,Xue Bai,Jiagui Huang,Yue Chen,Jun Wen,Xuemei Li,Bowen Wu,Yongjun Tan,Mingfen Tian,Jiangxia Ren,Mengxia Li,Qin Yang
DOI: https://doi.org/10.1186/s13287-022-02876-2
2022-05-14
Abstract:Ischemic stroke is one of the major causes of death and disability in the world. Currently, most patients cannot choose intravenous thrombolysis or intravascular mechanical thrombectomy because of narrow therapeutic windows and severe complications. Stem cell transplantation is an emerging treatment and has been studied in various central nervous system diseases. Animal and clinical studies showed that transplantation of mesenchymal stem cells (MSCs) could alleviate neurological deficits and bring hope for ischemic stroke treatment. This article reviewed biological characteristics, safety, feasibility and efficacy of MSCs therapy, potential therapeutic targets of MSCs, and production process of Good Manufacturing Practices-grade MSCs, to explore the potential therapeutic targets of MSCs in the process of production and use and provide new therapeutic directions for ischemic stroke.
cell biology,medicine, research & experimental,cell & tissue engineering
What problem does this paper attempt to address?